KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160,784 | -53.8% | 114,846 | 0.0% | 0.00% | – |
| Q2 2023 | $347,983 | -58.1% | 114,846 | -13.6% | 0.00% | – |
| Q1 2023 | $830,500 | +4.0% | 132,880 | +1.5% | 0.00% | – |
| Q4 2022 | $798,795 | -48.9% | 130,950 | +0.1% | 0.00% | -100.0% |
| Q3 2022 | $1,563,000 | -6.6% | 130,754 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $1,674,000 | +12.6% | 132,705 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $1,487,000 | -37.2% | 132,038 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $2,369,000 | -22.6% | 133,696 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $3,059,000 | +4.0% | 132,866 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $2,941,000 | +248.0% | 126,311 | +365.6% | 0.00% | – |
| Q1 2021 | $845,000 | – | 27,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 3,525,957 | $4,936,340 | 7.88% |
| Foresite Capital Management IV, LLC | 9,671,643 | $13,540,300 | 7.52% |
| Vida Ventures Advisors, LLC | 2,207,772 | $3,090,881 | 4.78% |
| Lynx1 Capital Management LP | 1,997,006 | $2,795,808 | 1.85% |
| Nextech Invest Ltd. | 2,329,480 | $3,261,272 | 0.99% |
| Orbimed Advisors | 8,009,729 | $11,213,621 | 0.24% |
| Novo Holdings A/S | 815,707 | $1,141,990 | 0.08% |
| DAFNA Capital Management LLC | 105,179 | $147,251 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 374,291 | $524 | 0.04% |
| Rock Springs Capital Management LP | 405,811 | $568,135 | 0.02% |